As hub transitions accelerate and digital tools reshape how support is delivered, four patient services experts weigh in on what's driving change in 2026, and what manufacturers need to get right to ...
As hub transitions accelerate and digital tools reshape how support is delivered, four patient services experts weigh in on what's driving change in 2026, and what manufacturers need to get right to ...
As hub transitions accelerate and digital tools reshape how support is delivered, four patient services experts weigh in on what's driving change in 2026, and what manufacturers need to get right to ...
Shawn Seamans, Chief Commercial Officer, CoverMyMeds | Authors | Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking ...
As China tightens supply chain rules, tariff pressure persists, and the FDA's PreCheck Program takes shape, this FAQ breaks down how pharma reshoring stands in 2026. The FDA selected seven companies, ...
Claims target comparative ads that juxtapose tirzepatide’s maximum tolerated doses with semaglutide regimens that omit FDA-approved higher strengths, potentially creating a misleading efficacy ...
Semmelweis combines frontier LLM reasoning with proprietary clinical grounding using an identity graph of 6+ million verified HCPs, 185+ EHR integrations, and live Clinical Intent Signals. A bounded ...
2026 commercial dynamics are defined by a widening gap between firms with strong order-book visibility and those facing protracted uncertainty, rather than a clean “two halves” cycle. Marketing ...
Cencora's Brent Wilhelm explains why final-mile drug delivery hinges on carrier network visibility, and how AI is helping route around weather-driven disruptions. In part 2 of a 3-part interview with ...
Continuous in-transit monitoring shifts cold chain control from post-delivery forensics to proactive intervention, enabling rerouting, expedited handoffs, and mid-journey coolant replenishment before ...
Brent Wilhelm of Cencora discusses why available inventory still leads to shortages, and how tighter distributor-manufacturer integration and AI could close the gap. In part 1 of a 3-part interview ...
Episode 1 of Supply Chain Signal breaks down the FDA's PreCheck pilot, the US Section 301 probe into German drug pricing, and CMS's move to make Medicare drug price negotiation permanent. The debut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results